Federal contract award
HHSO100201600021C
MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONSEXPANDED ACCESS PROTOCOL FOR ZMAPP
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541720 — Research and Development in the Social Sciences and Humanities |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $28.9M |
| Current contract value | $28.9M |
| Potential contract value / ceiling | $28.9M |
| Start date | Jun 27, 2016 |
| Current end date | Dec 31, 2027 |
| Potential end date | Dec 31, 2027 |
| Latest award activity | Jul 20, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 42 of 42 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 20, 2026 | P00041 | $0 | RECEIVE GFP FROM CONTRACT 75A50122C00061 |
| May 7, 2026 | P00040 | $0 | UPDATE INDIRECT RATES; UPDATE FAR AND HHSAR CLAUSES |
| Mar 17, 2026 | P00039 | $0 | RECEIVE GOVERNMENT FURNISHED PROPERTY (GFP) FROM MAPP CONTRACTS 75A502122C00061 AND 75A50122C00076 |
| Jan 15, 2026 | P00038 | $0 | ADD CLINICAL COMPATIBILITY STUDY FOR CLIN 0005/WBS 1.4.4 TO THE STATEMENT OF WORK (SOW) |
| Sep 4, 2025 | P00037 | $-2.1M | CANCELLING FUNDS UNDER REQUISITION OS240615 UNDER CLIN 0001 EXPIRING 10/01/2025 |
| Jul 17, 2025 | P00036 | $0 | MAPP BIOPHARMACEUTICAL - RECEIVE GFP FROM MAPP CONTRACT 75A50122C00061 AND UPDATE COR AND ALTERNATE COR |
| May 6, 2025 | P00035 | $0 | MAPP BIOPHARMACEUTICAL - UPDATE INDIRECT RATES |
| Apr 7, 2025 | P00034 | $0 | MAPP BIOPHARMACEUTICAL - RECEIVE GFP TRANSFER FROM MAPP BIOPHARMACEUTICAL CONTRACT 75A50122C00061 |
| Mar 27, 2025 | P00033 | $0 | SUPPORT THE INITIATION, MAINTENANCE, AND EXECUTION OF A ZMAPP EAP IN THE US AND AFRICA, INCLUDING CLINICAL, QUALITY, REGULATORY, AND OPERATIONAL SUPPORT AS WELL AS THE EARLY CLINICAL STUDIES (PHASE 1) REQUIRED TO ENABLE FIELD USE OF MBP091 AND MBP134 |
| Jan 29, 2025 | P00032 | $0 | SUPPORT THE INITIATION, MAINTENANCE, AND EXECUTION OF A ZMAPP EAP IN THE US AND AFRICA, INCLUDING CLINICAL, QUALITY, REGULATORY, AND OPERATIONAL SUPPORT AS WELL AS THE EARLY CLINICAL STUDIES (PHASE 1) REQUIRED TO ENABLE FIELD USE OF MBP091 AND MBP134 |
| Dec 19, 2024 | P00031 | $0 | SUPPORT THE INITIATION, MAINTENANCE, AND EXECUTION OF A ZMAPP EAP IN THE US AND AFRICA, INCLUDING CLINICAL, QUALITY, REGULATORY, AND OPERATIONAL SUPPORT AS WELL AS THE EARLY CLINICAL STUDIES (PHASE 1) REQUIRED TO ENABLE FIELD USE OF MBP091 AND MBP134 |
| Dec 9, 2024 | P00030 | $0 | SUPPORT THE INITIATION, MAINTENANCE, AND EXECUTION OF A ZMAPP EAP IN THE US AND AFRICA, INCLUDING CLINICAL, QUALITY, REGULATORY, AND OPERATIONAL SUPPORT AS WELL AS THE EARLY CLINICAL STUDIES (PHASE 1) REQUIRED TO ENABLE FIELD USE OF MBP091 AND MBP134 |
| Dec 3, 2024 | P00029 | $0 | SUPPORT THE INITIATION, MAINTENANCE, AND EXECUTION OF A ZMAPP EAP IN THE US AND AFRICA, INCLUDING CLINICAL, QUALITY, REGULATORY, AND OPERATIONAL SUPPORT AS WELL AS THE EARLY CLINICAL STUDIES (PHASE 1) REQUIRED TO ENABLE FIELD USE OF MBP091 AND MBP134 |
| Aug 7, 2024 | P00028 | $0 | SUPPORT THE INITIATION, MAINTENANCE, AND EXECUTION OF A ZMAPP EAP IN THE US AND AFRICA, INCLUDING CLINICAL, QUALITY, REGULATORY, AND OPERATIONAL SUPPORT AS WELL AS THE EARLY CLINICAL STUDIES (PHASE 1) REQUIRED TO ENABLE FIELD USE OF MBP091 AND MBP134 |
| Jul 10, 2024 | P00027 | $0 | SUPPORT THE INITIATION, MAINTENANCE, AND EXECUTION OF A ZMAPP EAP IN THE US AND AFRICA, INCLUDING CLINICAL, QUALITY, REGULATORY, AND OPERATIONAL SUPPORT AS WELL AS THE EARLY CLINICAL STUDIES (PHASE 1) REQUIRED TO ENABLE FIELD USE OF MBP091 AND MBP134 |
| Dec 13, 2023 | P00026 | $0 | SUPPORT THE INITIATION, MAINTENANCE, AND EXECUTION OF A ZMAPP EAP IN THE US AND AFRICA, INCLUDING CLINICAL, QUALITY, REGULATORY, AND OPERATIONAL SUPPORT AS WELL AS THE EARLY CLINICAL STUDIES (PHASE 1) REQUIRED TO ENABLE FIELD USE OF MBP091 AND MBP134 |
| Dec 12, 2023 | P00025 | $0 | SUPPORT THE INITIATION, MAINTENANCE, AND EXECUTION OF A ZMAPP EAP IN THE US AND AFRICA, INCLUDING CLINICAL, QUALITY, REGULATORY, AND OPERATIONAL SUPPORT AS WELL AS THE EARLY CLINICAL STUDIES (PHASE 1) REQUIRED TO ENABLE FIELD USE OF MBP091 AND MBP134 |
| Jul 11, 2023 | P00024 | $0 | SUPPORT THE INITIATION, MAINTENANCE, AND EXECUTION OF A ZMAPP EAP IN THE US AND AFRICA, INCLUDING CLINICAL, QUALITY, REGULATORY, AND OPERATIONAL SUPPORT AS WELL AS THE EARLY CLINICAL STUDIES (PHASE 1) REQUIRED TO ENABLE FIELD USE OF MBP091 AND MBP134 |
| Feb 3, 2023 | P00023 | $0 | SUPPORT THE INITIATION, MAINTENANCE, AND EXECUTION OF A ZMAPP EAP IN THE US AND AFRICA, INCLUDING CLINICAL, QUALITY, REGULATORY, AND OPERATIONAL SUPPORT AS WELL AS THE EARLY CLINICAL STUDIES (PHASE 1) REQUIRED TO ENABLE FIELD USE OF MBP091 AND MBP134 |
| Sep 28, 2022 | P00022 | $0 | SUPPORT THE INITIATION, MAINTENANCE, AND EXECUTION OF A ZMAPP EAP IN THE US AND AFRICA, INCLUDING CLINICAL, QUALITY, REGULATORY, AND OPERATIONAL SUPPORT AS WELL AS THE EARLY CLINICAL STUDIES (PHASE 1) REQUIRED TO ENABLE FIELD USE OF MBP091 AND MBP134 |
| Sep 21, 2022 | P00021 | $2.4M | SUPPORT THE INITIATION, MAINTENANCE, AND EXECUTION OF A ZMAPP EAP IN THE US AND AFRICA, INCLUDING CLINICAL, QUALITY, REGULATORY, AND OPERATIONAL SUPPORT AS WELL AS THE EARLY CLINICAL STUDIES (PHASE 1) REQUIRED TO ENABLE FIELD USE OF MBP091 AND MBP134 |
| May 23, 2022 | P00020 | $0 | CORRECT AN ADMINISTRATIVE ERROR AND PROPERLY REFLECT THE ACCURATE PERIOD OF PERFORMANCE FOR CLIN 0001 AND CLIN 0005 |
| May 5, 2022 | P00019 | $0 | ADD CLAUSE IMPLEMENTING THE INVOICING PROCESSING PLATFORM (IPP) |
| Mar 30, 2022 | P00018 | $0 | UPDATE ARTICLE G7 - INDIRECT COST RATE TABLE |
| Mar 21, 2022 | P00017 | $0 | TRANSFER OF GOVERNMENT FURNISHED PROPERTY |
| Jan 18, 2022 | P00016 | $915.0K | INCORPORATE REVISED STATEMENT OF WORK AND ADD FUNDING FOR CLIN 0005 |
| Nov 16, 2021 | P00015 | $0 | INCORPORATE FAR DEVIATION CLAUSE 52.223-99, ENSURING ADEQUATE COVID SAFETY PROTOCOLS FOR FEDERAL CONTRACTORS |
| Jan 28, 2021 | P00014 | $0 | TO ENABLE THE EXPANDED ACCESS PROTOCOL (EAP) FOR ZMAPP FOR THERAPEUTIC TREATMENT OF PATIENTS WITH CONFIRMED EBOLA VIRUS DISEASE OR POST-EXPOSURE PROPHYLACTIC TREATMENT OF PATIENTS FOLLOWING HIGH-RISK EXPOSURE TO THE EBOLA VIRUS. |
| Jan 6, 2021 | P00013 | $0 | TO ENABLE THE EXPANDED ACCESS PROTOCOL (EAP) FOR ZMAPP FOR THERAPEUTIC TREATMENT OF PATIENTS WITH CONFIRMED EBOLA VIRUS DISEASE OR POST-EXPOSURE PROPHYLACTIC TREATMENT OF PATIENTS FOLLOWING HIGH-RISK EXPOSURE TO THE EBOLA VIRUS. |
| Jun 30, 2020 | P00012 | $0 | TO ENABLE THE EXPANDED ACCESS PROTOCOL (EAP) FOR ZMAPP FOR THERAPEUTIC TREATMENT OF PATIENTS WITH CONFIRMED EBOLA VIRUS DISEASE OR POST-EXPOSURE PROPHYLACTIC TREATMENT OF PATIENTS FOLLOWING HIGH-RISK EXPOSURE TO THE EBOLA VIRUS. |
| Sep 26, 2019 | P00011 | $0 | MAPP 021C - MOD #00007 - MAPP EAP EXPANDED ACCESS PROTOCOL FOR ZMAPP |
| Sep 18, 2019 | P00010 | $0 | MAPP 021C - MOD #00007 - MAPP EAP EXPANDED ACCESS PROTOCOL FOR ZMAPP |
| May 16, 2019 | P00009 | $8.6M | MAPP 021C - MOD #00007 - MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONS EXPANDED ACCESS PROTOCOL FOR ZMAPP |
| Mar 4, 2019 | 8 | $0 | MAPP 021C - MOD #00007 - MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONS EXPANDED ACCESS PROTOCOL FOR ZMAPP |
| Sep 28, 2018 | 7 | $1.9M | MAPP 021C - MOD #00007 - MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONS EXPANDED ACCESS PROTOCOL FOR ZMAPP |
| May 1, 2018 | 6 | $0 | MAPP 021C - MOD #00004 - MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONS EXPANDED ACCESS PROTOCOL FOR ZMAPP |
| Jan 31, 2018 | 5 | $0 | MAPP 021C - MOD #00004 - MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONS EXPANDED ACCESS PROTOCOL FOR ZMAPP |
| Aug 4, 2017 | 4 | $1.6M | MAPP 021C - MOD #00004 - MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONS EXPANDED ACCESS PROTOCOL FOR ZMAPP |
| Jun 27, 2017 | 3 | $676.8K | MAPP 021C - MOD #00003 - MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONS EXPANDED ACCESS PROTOCOL FOR ZMAPP |
| Mar 6, 2017 | 2 | $57.6K | MAPP 021C - MOD #00002 - MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONS EXPANDED ACCESS PROTOCOL FOR ZMAPP |
| Sep 12, 2016 | 1 | $1.5M | MAPP 021C - MOD #00001 - MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONS EXPANDED ACCESS PROTOCOL FOR ZMAPP |
| Jun 24, 2016 | 0 | $13.4M | MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONSEXPANDED ACCESS PROTOCOL FOR ZMAPP |
Estimated positioning window
Dec 31, 2026 – Jun 30, 2027
Recompete signal: . Rule-based research score; positioning dates are estimates.
55/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 55/100. Available recorded signals: 50 points.
- Contract end 2027-12-31 (432 days from calculation)
- +25 points
- 1 historical awards in this buyer and category group
- +0 points
- 42 recorded award transactions
- +10 points
- Latest award action: 2026-07-20
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.